Geoffrey Beran Rose - 10 Mar 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: Chief Commercial Officer
Signature: /s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Issuer symbol: LUNG
Transactions as of: 10 Mar 2022
Net transactions value: +$61,797
Form type: 4
Filing time: 11 Mar 2022, 17:06:39 UTC
Previous filing: 03 Mar 2022
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Options Exercise	$61,797	+29,427	+19%	$2.10^*	184,129	10 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Options Exercise	$0	-29,427	-62%	$0.000000	18,192	10 Mar 2022	Common Stock	29,427	$2.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on October 2, 2019, subject to the Reporting Person's continuous service through each such vesting date.